Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-29 06:11 am Sale | 2024-12-31 | 13G | Electrovaya Inc. ELVA | HIRSCHMAN ORIN | 2,515,099 6.300% | -838,209 (-25.00%) | Filing History |
| 2025-01-29 06:08 am Purchase | 2024-12-31 | 13G | Arq, Inc. ARQ | HIRSCHMAN ORIN | 3,012,956 7.200% | 674,220 (+28.83%) | Filing History |
| 2025-01-27 10:07 am Sale | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | HIRSCHMAN ORIN | 2,022,221 4.900% | -640,103 (-24.04%) | Filing History |
| 2025-01-23 3:34 pm Sale | 2024-12-31 | 13G | BK Technologies Corporation BKTI | HIRSCHMAN ORIN | 268,180 7.500% | -62,716 (-18.95%) | Filing History |
| 2025-01-21 11:57 am Purchase | 2024-12-31 | 13G | Verastem, Inc. VSTM | HIRSCHMAN ORIN | 2,717,827 6.100% | 2,717,827 (New Position) | Filing History |
| 2024-11-08 4:51 pm Sale | 2024-11-05 | 13G | Delcath Systems, Inc. DCTH | HIRSCHMAN ORIN | 1,472,312 4.600% | -67,326 (-4.37%) | Filing History |
| 2024-10-29 7:47 pm Unchanged | 2024-10-29 | 13G | Evoke Pharma, Inc. EVOK | HIRSCHMAN ORIN | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-10-09 5:19 pm Purchase | 2024-10-01 | 13G | IN8bio, Inc. INAB | HIRSCHMAN ORIN | 6,737,932 9.300% | 4,403,264 (+188.60%) | Filing History |
| 2024-10-09 4:05 pm Sale | 2024-10-02 | 13G | Eagle Pharmaceuticals, Inc. EGRX | HIRSCHMAN ORIN | 0 0.000% | -1,061,509 (Position Closed) | Filing History |
| 2024-09-17 7:30 pm Sale | 2024-06-14 | 13G | IN8bio, Inc. INAB | HIRSCHMAN ORIN | 2,334,668 4.990% | -1,763,693 (-43.03%) | Filing History |
| 2024-08-19 06:03 am Purchase | 2024-08-16 | 13G | Personalis, Inc. PSNL | HIRSCHMAN ORIN | 4,394,064 6.700% | 1,394,064 (+46.47%) | Filing History |
| 2024-07-26 12:56 pm Purchase | 2024-07-19 | 13G | Personalis, Inc. PSNL | HIRSCHMAN ORIN | 3,000,000 5.800% | 3,000,000 (New Position) | Filing History |
| 2024-07-16 06:02 am Sale | 2024-07-15 | 13G | Red Cat Holdings, Inc. RCAT | HIRSCHMAN ORIN | 3,000,000 4.000% | -2,026,104 (-40.31%) | Filing History |
| 2024-06-11 4:05 pm Sale | 2024-06-10 | 13G | KWESST Micro Systems Inc. KWE | HIRSCHMAN ORIN | 0 0.000% | -55,618 (Position Closed) | Filing History |
| 2024-06-05 07:26 am Purchase | 2024-05-09 | 13G | Plus Therapeutics, Inc. PSTV | HIRSCHMAN ORIN | 568,681 9.900% | 568,681 (New Position) | Filing History |
| 2024-05-30 08:42 am Purchase | 2024-05-16 | 13G | Arq, Inc. ARQ | HIRSCHMAN ORIN | 2,338,736 6.500% | 2,338,736 (New Position) | Filing History |
| 2024-04-09 09:13 am Purchase | 2024-03-25 | 13G | Ideal Power Inc. IPWR | HIRSCHMAN ORIN | 700,000 9.500% | 700,000 (New Position) | Filing History |
| 2024-04-09 08:49 am Purchase | 2024-03-25 | 13G | Intellicheck, Inc. IDN | HIRSCHMAN ORIN | 1,598,953 8.200% | 1,598,953 (New Position) | Filing History |
| 2024-04-09 08:46 am Purchase | 2024-03-27 | 13G | Acasti Pharma Inc. ACST | HIRSCHMAN ORIN | 567,812 6.000% | 567,812 (New Position) | Filing History |
| 2024-03-25 9:52 pm Sale | 2024-03-22 | 13G | Apyx Medical Corporation APYX | HIRSCHMAN ORIN | 0 0.000% | -2,040,540 (Position Closed) | Filing History |